Evaluation of clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones

Journal of Managed Care Pharmacy

Volumn 14, Issue 1, 2008, Pages 34-40

  Walbrown, Molly A ^a   Aspinall, Sherrie L ^b,c,d   Bayliss, Nichole K ^c   Stone, Roslyn A ^c,e   Cunningham, Francesca ^b   Squier, Cheryl L ^b,c,f   Good, Chester B ^b,c,f  

^a YORK HOSPITAL   (United States)

^b VA Center for Medication Safety

^c Center for Health Equity Research and Promotion   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DRUG FORMULARY; DRUG PREFERENCE; DRUG USE; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; INCIDENCE; INFECTION; INFECTIOUS DIARRHEA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POISSON DISTRIBUTION; PRESCRIPTION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; UNITED STATES;

EID: 40149108050     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2008.14.1.34     Document Type: Article

References (30)